# BOMYNTRA

NDC: 65219-672
Generic name: Denosumab
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20250630

FDA application: BLA761398

## Active ingredients

- DENOSUMAB: 70 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65219-672"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65219-672
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=49d25732-e05d-47e4-98cb-67df04796d4b